4-Ethylphenyl Sulfate: Assay Design
2026-08-16
4-Ethylphenyl sulfate is a microbiota-derived metabolite linking renal and neurobehavioral research. This guide introduces a matrix-aware strategy for interpreting biomarker, mouse-model, and blood-contacting material assays.
Troglitazone: PPARγ Agonist Workflows
2026-08-15
Troglitazone gives researchers a practical way to connect PPARγ/α signaling with lipid and glucose metabolism, macrophage state, and exploratory renal carcinoma assays. This guide translates the SPP1-focused tumor-myeloid study into controlled, product-specific workflows without overstating what the reference directly tested.
Abiraterone Acetate in 3D Prostate Models
2026-08-15
Abiraterone acetate is a CYP17 inhibitor that can reveal how androgen biosynthesis shapes prostate tumor biology. This evidence-led guide explains why patient-derived 3D spheroids may show weak viability responses, and how to pair pathway and structural readouts for more informative prostate cancer research.
TAI-1 Hec1 Inhibitor Workflow Guide
2026-08-14
TAI-1 enables mechanism-led studies of Hec1–Nek2 disruption, mitotic failure, and apoptotic cell death induction across cancer models. This guide connects dose-response, combination, and retinal organoid workflows while distinguishing reported product performance from practical assay starting points.
Rucaparib Workflows for DNA Repair Research
2026-08-14
Build reproducible Rucaparib experiments for PARP biology, irradiation studies, and spliceosome-linked drug sensitivity. This guide combines practical treatment matrices, damage-response readouts, and troubleshooting for models ranging from hepatocellular carcinoma to prostate cancer.
DOTAP and the Next Wave of Translational Delivery
2026-08-13
1,2-Dioleoyl-3-trimethylammonium-propane chloride, or DOTAP, provides a practical bridge between controlled nucleic acid delivery and emerging immune-metabolic research. This thought-leadership analysis explains the delivery mechanism, validation strategy, translational limits, and opportunities for lipid nanoparticle optimization inspired by recent Nano-ZD findings.
VX-745: Practical p38α MAPK Assay Guide
2026-08-13
This scenario-based guide explains how VX-745, SKU A8686, can support interpretable cell viability, proliferation, cytotoxicity, and cytokine assays. It connects documented p38α selectivity and formulation characteristics with practical controls, dosing logic, and evidence-aware data interpretation.
Nadolol (SQ-11725): A Transporter-Aware Assay Guide
2026-08-12
Nadolol (SQ-11725) is a non-selective beta-adrenergic antagonist for designing rigorous cardiovascular assays. This guide adds a transporter-aware pharmacokinetic framework, using disease-state tissue distribution research to improve interpretation beyond receptor pharmacology alone.
Acetylspiramycin for Resistance Research
2026-08-12
Acetylspiramycin (Spiramycin B) provides a practical comparator for studying macrolide-resistant Mycoplasma pneumoniae and ribosome-directed antibacterial activity. This guide translates recent Beijing surveillance findings into reproducible susceptibility workflows, formulation controls, and troubleshooting strategies while separating MIC evidence from clinical conclusions.
Azilsartan in Astrocyte–Microglia Assays
2026-08-11
Azilsartan and TAK-536 provide a precise pharmacological entry point for studying AT1 signaling beyond blood-pressure biology. This guide translates the gastrodin–RAS–SIRT3 study into practical assay design, formulation, controls, and interpretation strategies for neuroinflammation research.
ER Stress and Intestinal Stem Cell Loss
2026-08-10
The reference study links tunicamycin-induced endoplasmic reticulum stress to intestinal stem-cell depletion, impaired epithelial differentiation, reduced crypt proliferation, and increased apoptosis in mice. Its central contribution is a mechanistic model in which GRP78/ATF6/CHOP activation and suppression of p44/42 MAPK signaling connect ER stress with intestinal mucosal injury.
Viral RIPK3 Degradation in Orthopoxvirus Inflammation
2026-08-09
The reference study identifies a viral inducer of RIPK3 degradation, or vIRD, that hijacks the host SCF ubiquitin ligase machinery to suppress necroptosis. By combining genetic, biochemical, virological, and mouse experiments, the authors show that vIRD controls orthopoxvirus replication, inflammation, and disease severity through the RIPK3–MLKL pathway.
CD38 CAR Binder Structures and Affinity Tuning
2026-08-08
Cheng et al. structurally and functionally distinguish how the CD38 CAR binders RP02 and 028 engage the antigen, inhibit its enzymatic activity, and influence CAR-T behavior. The study shows that rational affinity attenuation of 028 can reduce fratricide while preserving antitumor cytotoxicity, offering a structure-guided framework for balancing potency, selectivity, and safety.
U-73122 Workflows for PLC Signaling and Invasion
2026-08-07
U-73122 is a practical phospholipase C inhibitor for connecting PLC activity with calcium flux, neutrophil chemotaxis, and cancer-cell invasion. This guide combines concentration planning, assay workflows, reference-driven interpretation, and troubleshooting for more reproducible PLC signaling pathway modulation.
Cycloheximide: Protein Biosynthesis Inhibitor in Advanced As
2026-08-07
Cycloheximide (APExBIO, SKU A8244) is a best-in-class protein biosynthesis inhibitor, empowering apoptosis studies, protein turnover assays, and precise translational control in cell and animal models. This guide integrates new insights from viral export research and delivers actionable optimization tips, workflow enhancements, and troubleshooting strategies for advanced research needs.
470 records 9/32 page Previous Next First page 上5页 678910 下5页 Last page